Hour-Specific Total Serum Bilirubin Percentiles for Infants Born at 29-35 Weeks' Gestation

Thivia Jegathesan1,2, Joel G Ray1,3,4, Vinod K Bhutani5

  • 1Institute of Medical Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Neonatology
|October 28, 2021
PubMed

Insights

This study establishes hour-specific total serum bilirubin (TSB) percentile cut-points for preterm infants, aiding in hyperbilirubinemia monitoring. These novel nomograms provide crucial data for clinical decision-making in neonatal care.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology

Background:

  • Preterm infants are highly susceptible to hyperbilirubinemia, necessitating vigilant monitoring.
  • Current clinical practice lacks established hour-specific total serum bilirubin (TSB) percentile cut-points for preterm neonates.
  • This deficiency hinders timely and accurate assessment of hyperbilirubinemia risk prior to phototherapy initiation.

Purpose of the Study:

  • To develop and present hour-specific TSB percentile nomograms for preterm infants.
  • To provide a data-driven tool for describing bilirubin levels in relation to gestational age and postnatal age.
  • To inform clinical management and research regarding hyperbilirubinemia in this vulnerable population.

Main Methods:

  • A retrospective cohort study was conducted involving 2,549 preterm infants (290/7-356/7 weeks' gestation) across three NICUs in Ontario, Canada.
  • Data from 6,143 pre-treatment TSB levels were collected between January 2013 and June 2017.
  • Hour-specific TSB percentiles were generated using quantile regression, stratified by gestational age and phototherapy status.

Main Results:

  • Hour-specific TSB percentiles at birth, 75th, and 95th were established for the overall cohort.
  • Distinct percentile values were reported for infants who received phototherapy versus those who did not.
  • Significant differences in TSB percentiles were observed based on degree of prematurity (29-32 weeks vs. 33-35 weeks' gestation).

Conclusions:

  • The developed hour-specific TSB percentile nomograms offer a novel method for characterizing bilirubin levels in preterm newborns.
  • These nomograms may assist in the standardized description and interpretation of TSB levels.
  • Further research is warranted to validate and integrate these pre-treatment TSB level findings into routine clinical practice.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
33
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
514
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
29
Quartile01:15

Quartile

Quartiles are numbers that separate the data into quarters. Quartiles may or may not be part of the data. To find the quartiles, first, find the median or second quartile. The first quartile, Q1, is the middle value of the lower half of the data, and the third quartile, Q3, is the middle value, or median, of the upper half of the data. To get the idea, consider the same data set:
1; 1; 2; 2; 4; 6; 6.8; 7.2; 8; 8.3; 9; 10; 10; 11.5
The median or second quartile is seven. The lower half of the...
6.9K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
139